All Type of News
Will the pharmaceutical industry, which is busy forming business departments, establish the specialization plan?
According to the industry concerned, some pharmaceutical companies, such as SK Group, Daewoong Pharmaceutical and Kukje Pharm, have either formed a new business department or started to be partially specialized by sel...
The pharmaceutical market grows average 3.5% every year while the market share of generics decreases
It is anticipated that although the volume of the Korean pharmaceutical market has been enlarged, the proportion of generics will decrease.
According to the IMS Health’s report called “IMS Market Prognosis 2015-2019,...
Listed pharmaceutical companies spent more than KRW 100 billion in advertisements on the 1st quarter
It is observed that listed pharmaceutical companies spent more than KRW 100 billion in advertisements on the last 1st quarter, making a 18% increase over the same quarter last year.
According to the YakupDotCom’s ana...
Samsung Biologics attracts the industry by the M&A of Cheil Industries and Samsung C&T Corporation
As the M&A between Cheil Industries and Samsung C&T Corporation is confirmed, growth of Samsung Biologics is expected to be accelerated.
Samsung Group, planning to complete the M&A of Cheil Industries and Samsung C&T...
Will unprecedented movements of Alvogen bear fruit?
The American generic-centered pharmaceutical company, Alvogen, is about to finish its 3-year expansion project to the Korean market, and started to move towards the new goal to become the top 5 in the Asia-Pacific reg...
The Supreme Court decision over Baraclude established a ground for the patent acceptance of usage and volume
The hepatitis type B treatment ‘Baraclude’ patent suit, won by Jeil Pharm on the last 21st, has attracted interests of the pharmaceutical industry as founding a ground for pharmaceutical products to be accepted in usa...
Mid-sized pharmaceutical companies have raised complaints over the Rebate Secret Survey
When it comes to the ‘Rebate Secret Survey’ conducted by the Korea Pharmaceutical Manufacturers Association (KPMA) to settle ethical management and rebate eradication, a part of the pharmaceutical industry has begun t...
The KRW 150 billion antidepressant market has fallen into chaos with emergence of Pristiq
The domestic antidepressant treatment market is estimated to be approximately KRW 150 billion in accordance to the end of the last year,
The most frequently used SSRI-type products are ‘Prozac (fluoxetine),’ ‘Zoloft(...
A series of pharmaceutical companies pushing forward with IPOs once again this year
Many affiliated companies of pharmaceutical companies have attracted the pharmaceutical industry with IPO(Initial Public Offering); for instance, Kyongbo Pharm, which has passed the preliminary examination to enter th...
Will Pfizer and BMS work on the revival of Eliquis?
Co-marketing, joint operation or joint cultivation may lead to an immediate failure once cooperative companies start to consider it as a task of the other. In this context, outstanding multinational pharmaceutical com...
